Pivotal NGN-401 trial speeds toward dosing for people with Rett
NGN-401, a gene therapy treatment people with Rett syndrome, has shown positive results from an ongoing Phase 1/2 trial.| Rett Syndrome News
Enrollment is complete for the randomized part of ENHANCE, a large clinical trial testing a new dosing schedule for Briumvi (ublituximab-xiiy) in adults with relapsing forms of multiple sclerosis (MS), […] The post ENHANCE trial testing simplified Briumvi dosing now fully enrolled appeared first on Multiple Sclerosis News Today.| Multiple Sclerosis News Today – The Web's Daily Resource for Multiple Scler...
NGN-401, a gene therapy treatment people with Rett syndrome, has shown positive results from an ongoing Phase 1/2 trial.| Rett Syndrome News
Dr. Beal discusses a May, 2024 paper on estradiol valerate dosing guidelines and how this paper validates our clinical knowledge and practice. Hint: smaller| QueerDoc • Transgender and Gender Diverse Online Healthcare
According to the Alzheimer’s Association, the number of Americans living with Alzheimer’s is 5.8 million and that number is expected to reach 14 million by 2050. Currently 1 out of 3 seniors die with dementia or Alzheimer’s and it is the 6thleading cause of death in the U.S. In 2019, the estimated cost of treating […] The post #53 PRIME TIME: Case Study Shows Less Can be More first appeared on Mary's Medicinals. The post #53 PRIME TIME: Case Study Shows Less Can be More appeared first...| Mary's Medicinals
